Forbes: App helps connect isolated seniors with their families

The app, HiLois, links senior citizens with family members during social distancing

With the coronavirus pandemic, which has shuttered elder care facilities to visitors across the U.S. in the name of social distancing, a sudden spotlight has been given to services like HiLois, a private social network designed for seniors and their families.  

Brett Harnett, HiLois founder and assistant professor in UC's Department of Biomedical Informatics, came up with the idea for the app shortly after his mother’s Alzheimer’s diagnosis in 2014, as a way to remotely share photos and messages with her while living hundreds of miles away.

Now, facilities are reaching out to find out how they, too, can utilize the tool and connect residents with families. 

“These facilities, they’re playing tic-tac-toe with masking tape on the windows, holding up signs, chalkboards, whiteboards. This is their level of communication,” Harnett told Forbes. “They’re also bombarded by calls from families saying, ‘Does someone in there have an iPhone? I want to FaceTime with my mom.’ These organizations don’t have the resources to do that. This is what we’ve been hearing for years: that their resources are really thin.”

Read more about HiLois.

Featured photo courtesy of Rod Long/Unsplash. 

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Read more #UCtheGood stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.

Related Stories

2

What's behind the mysterious rise of migraines?

January 5, 2026

Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.

3

Top six 2025 nephrology drug approvals

January 5, 2026

“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.